132 related articles for article (PubMed ID: 19171798)
1. Detection of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infection.
Toni TA; Asahchop EL; Moisi D; Ntemgwa M; Oliveira M; Masquelier B; Brenner BG; Wainberg MA
Antimicrob Agents Chemother; 2009 Apr; 53(4):1670-2. PubMed ID: 19171798
[TBL] [Abstract][Full Text] [Related]
2. Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapy.
Metzner KJ; Rauch P; von Wyl V; Leemann C; Grube C; Kuster H; Böni J; Weber R; Günthard HF
J Infect Dis; 2010 Apr; 201(7):1063-71. PubMed ID: 20196655
[TBL] [Abstract][Full Text] [Related]
3. Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.
Coovadia A; Hunt G; Abrams EJ; Sherman G; Meyers T; Barry G; Malan E; Marais B; Stehlau R; Ledwaba J; Hammer SM; Morris L; Kuhn L
Clin Infect Dis; 2009 Feb; 48(4):462-72. PubMed ID: 19133804
[TBL] [Abstract][Full Text] [Related]
4. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients.
Metzner KJ; Rauch P; Braun P; Knechten H; Ehret R; Korn K; Kaiser R; Sichtig N; Ranneberg B; van Lunzen J; Walter H
J Clin Virol; 2011 Feb; 50(2):156-61. PubMed ID: 21056001
[TBL] [Abstract][Full Text] [Related]
6. Transmission dynamics of the M184V drug resistance mutation in primary HIV infection.
Wainberg MA; Moisi D; Oliveira M; Toni TD; Brenner BG
J Antimicrob Chemother; 2011 Oct; 66(10):2346-9. PubMed ID: 21750100
[TBL] [Abstract][Full Text] [Related]
7. Detection of residual human immunodeficiency virus type 1 reverse transcriptase K103N minority species in plasma RNA and peripheral blood mononuclear cell DNA following discontinuation of non-nucleoside therapy.
Saladini F; Vicenti I; Razzolini F; Zazzi M
Clin Microbiol Infect; 2010 Jul; 16(7):848-51. PubMed ID: 19681953
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina.
Vignoles M; Barboni G; Agosti MR; Quarleri J; García MK; Ayala SG; Salomón H
Antivir Ther; 2009; 14(8):1175-81. PubMed ID: 20032547
[TBL] [Abstract][Full Text] [Related]
9. Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients.
Metzner KJ; Scherrer AU; von Wyl V; Böni J; Yerly S; Klimkait T; Aubert V; Furrer H; Hirsch HH; Vernazza PL; Cavassini M; Calmy A; Bernasconi E; Weber R; Günthard HF;
AIDS; 2014 Sep; 28(15):2231-9. PubMed ID: 25036184
[TBL] [Abstract][Full Text] [Related]
10. Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients.
Metzner KJ; Giulieri SG; Knoepfel SA; Rauch P; Burgisser P; Yerly S; Günthard HF; Cavassini M
Clin Infect Dis; 2009 Jan; 48(2):239-47. PubMed ID: 19086910
[TBL] [Abstract][Full Text] [Related]
11. Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection.
Metzner KJ; Leemann C; Di Giallonardo F; Grube C; Scherrer AU; Braun D; Kuster H; Weber R; Guenthard HF
PLoS One; 2011; 6(7):e21734. PubMed ID: 21754996
[TBL] [Abstract][Full Text] [Related]
12. The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients.
Sasadeusz J; Audsley J; Mijch A; Baden R; Caro J; Hunter H; Matthews G; McMahon MA; Olender SA; Siliciano RF; Lewin SR; Thio CL
AIDS; 2008 May; 22(8):947-55. PubMed ID: 18453854
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.
Bokharaei-Salim F; Esghaei M; Khanaliha K; Kalantari S; Marjani A; Fakhim A; Keyvani H
PLoS One; 2020; 15(3):e0229275. PubMed ID: 32119691
[TBL] [Abstract][Full Text] [Related]
14. Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy.
Johnson JA; Li JF; Wei X; Lipscomb J; Irlbeck D; Craig C; Smith A; Bennett DE; Monsour M; Sandstrom P; Lanier ER; Heneine W
PLoS Med; 2008 Jul; 5(7):e158. PubMed ID: 18666824
[TBL] [Abstract][Full Text] [Related]
15. Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.
Escoto-Delgadillo M; Vázquez-Valls E; Ramírez-Rodríguez M; Corona-Nakamura A; Amaya-Tapia G; Quintero-Pérez N; Panduro-Cerda A; Torres-Mendoza BM
HIV Med; 2005 Nov; 6(6):403-9. PubMed ID: 16268822
[TBL] [Abstract][Full Text] [Related]
16. In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients.
Gianotti N; Galli L; Boeri E; Maillard M; Serra G; Ratti D; Gallotta G; Vacchini D; Tremolada Y; Lazzarin A; Clementi M; Castagna A
New Microbiol; 2005 Oct; 28(4):319-26. PubMed ID: 16386016
[TBL] [Abstract][Full Text] [Related]
17. Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia.
Mohamad S; Deris ZZ; Yusoff NK; Ariffin TA; Shueb RH
Braz J Infect Dis; 2012; 16(3):284-8. PubMed ID: 22729198
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of minor variants of HIV strains at reverse transcriptase position 103 in therapy-naïve patients and their impact on the virological failure.
Balduin M; Oette M; Däumer MP; Hoffmann D; Pfister HJ; Kaiser R
J Clin Virol; 2009 May; 45(1):34-8. PubMed ID: 19375978
[TBL] [Abstract][Full Text] [Related]
19. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
[TBL] [Abstract][Full Text] [Related]
20. Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System.
Cheung KW; Peng Q; He L; Cai K; Jiang Q; Zhou B; To SW; Yam WC; Liu L; Chen Z; Wang H
PLoS One; 2016; 11(4):e0153641. PubMed ID: 27092551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
